Skip to main content

Table 4 Demographic and clinical characteristics of the 48 colonized patients according to herpesvirus detection

From: Pulmonary co-infections by Pneumocystis jirovecii and Herpesviridae: a seven-year retrospective study

 

Colonization

without HV

(n = 20)

Colonization with

at least one HV

(n = 28)

p

value

Mean age ± SD (years)

62.2 +/- 12.6

63 +/- 13.1

0.84*

Male sex, n (%)

11 (55)

20 (71.4)

0.24**

Underlying disease, n (%)

 

Hematologic malignancy

6 (30)

13 (46.4)

0.25**

Solid organ or hematopoietic stem cell transplant

2 (10)

11 (39.3)

0.05**

Solid tumor

5 (25)

2 (7.1)

0.20**

Autoimmune disease

4 (20)

1 (3.5)

0.17**

Lung pathology

8 (40)

10 (35.7)

0.76**

HIV infection

0 (0)

0 (0)

NA

Comorbidity, n (%)

   

Cardiovascular disease

10 (50)

18 (64.2)

0.32**

Diabetes

0 (0)

6 (21.4)

0.07**

Renal insufficiency

0 (0)

2 (7.1)

0.62**

Immunosuppressive treatment, n (%)

   

Corticosteroids

5 (25)

12 (42.9)

0.20**

Cytotoxic chemotherapy

4 (20)

8 (28.6)

0.49**

Antiviral treatment, n (%)

2 (10)

4 (14.3)

1**

  1. HV, Herpesviridae; NA, not applicable; SD, standard deviation
  2. * Student’s test
  3. ** Chi-squared test